Skip to main content
CANF logo

CANF

Can-Fite BioPharma Ltd.
$3.91 -0.72 (-15.55%) At close · Jul 2
Market Cap
$8.38M
Shares
2,618,425

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 14
Total Value: $428,676
Total Shares: 138,284

Institutional Ownership Trend

2 quarters

Holder Concentration

Across 14 13F filers · Δ vs Dec 31, 2025
Top Holder
30.8%
Dec 2025 → Mar 2026 · range 30.8% – 100.0%
−69.2 pts
Top 5
93.9%
Dec 2025 → Mar 2026 · range 93.9% – 100.0%
−6.1 pts
Top 10
100.0%
Dec 2025 → Mar 2026 · range 100.0% – 100.0%
−0.0 pts
HHI
2,088
Dec 2025 → Mar 2026 · range 2,088 – 10,000
Moderately concentrated−7,912

Quarterly Activity

vs Dec 31, 2025
New
14
Increased
0
Decreased
0
Sold Out
1
Unchanged
0
Holder count: +13
Institutional value: +10716800.0%
Shares held: +13828300.0%

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 14 of 14
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1536196 CUSIP 13471N409 Visit website Investor relations